Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $53.9 million.

  • PROCEPT BioRobotics' Total Current Liabilities rose 46.97% to $53.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.9 million, marking a year-over-year increase of 46.97%. This contributed to the annual value of $53.1 million for FY2024, which is 1569.01% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' Total Current Liabilities stood at $53.9 million, which was up 46.97% from $49.7 million recorded in Q2 2025.
  • PROCEPT BioRobotics' 5-year Total Current Liabilities high stood at $53.9 million for Q3 2025, and its period low was $14.2 million during Q3 2021.
  • Its 5-year average for Total Current Liabilities is $36.8 million, with a median of $38.6 million in 2024.
  • As far as peak fluctuations go, PROCEPT BioRobotics' Total Current Liabilities skyrocketed by 12026.16% in 2023, and later soared by 46.97% in 2025.
  • Over the past 5 years, PROCEPT BioRobotics' Total Current Liabilities (Quarter) stood at $16.2 million in 2021, then skyrocketed by 117.28% to $35.3 million in 2022, then soared by 30.14% to $45.9 million in 2023, then rose by 15.69% to $53.1 million in 2024, then rose by 1.44% to $53.9 million in 2025.
  • Its last three reported values are $53.9 million in Q3 2025, $49.7 million for Q2 2025, and $52.1 million during Q1 2025.